Triple Moving Average Crossover
|Bid||14.80 x 800|
|Ask||15.29 x 3200|
|Day's Range||14.77 - 15.29|
|52 Week Range||7.75 - 17.25|
|Beta (5Y Monthly)||1.46|
|PE Ratio (TTM)||18.79|
|Earnings Date||Aug 12, 2020 - Aug 17, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||20.00|
Third Quarter Revenue of $56 million Third Quarter Adjusted EBITDA Increased 26% Year over Year Reiterates Fiscal 2020 Adjusted Earnings Per Share and EBITDA Guidance SALT.
LifeVantage (NASDAQ:LFVN) shares have had a really impressive month, gaining 51%, after some slippage. And the full...
SALT LAKE CITY, April 15, 2020 -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its third quarter ended March 31, 2020, after.
If you're interested in LifeVantage Corporation (NASDAQ:LFVN), then you might want to consider its beta (a measure of...
Today we'll evaluate LifeVantage Corporation (NASDAQ:LFVN) to determine whether it could have potential as an...
Record Second Quarter Revenue of $61 million, increased 5% year over year Second Quarter Adjusted EBITDA Increased 82% Reiterates Fiscal 2020 Guidance for Revenue and Adjusted.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
LifeVantage Corporation (LFVN) today announced preliminary revenue for the fiscal 2020 second quarter and six-month period ended Dec. 31, 2019. LifeVantage President and Chief Executive Officer Darren Jensen – who will ring the Nasdaq closing bell today in conjunction with Nasdaq “Wellness Week” – commented on preliminary revenue second quarter revenue figures. “This is a significant watermark for us as a company, particularly on the heels of achieving our highest annual revenue in company history during fiscal 2019,” Jensen said.
LifeVantage Corporation (LFVN) announced and launched an addition to its Protandim® line of nutrigenomic products during the company’s Elite Academy in Long Beach, Calif., over the weekend. “Our Protandim® line of synergizers is really what distinguishes us from other health and wellness companies, and we’re proud to introduce this latest breakthrough in nutrigenomic science and the newest member of the Protandim® family to the U.S. market,” said LifeVantage CEO Darren Jensen.
SALT LAKE CITY, July 31, 2019 -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its fourth quarter and full year ended June.
LifeVantage (LFVN) hosted its bi-annual Elite Academy in Kansas City, Missouri, over the weekend. As part of his welcome address, LifeVantage CEO Darren Jensen took attendees on a trip down memory lane, but also painted a picture of the coming decade. “We began in a lab with a single, powerful scientific discovery – a discovery that proved we, as humans, have more capacity, potential, and ability within us than we had been led to believe,” Jensen said.
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating the market further by examining what famous hedge fund operators such as Jeff Ubben, George Soros and Carl Icahn think. Those hedge fund operators make billions of […]
LifeVantage Corporation (NASDAQ:LFVN) shareholders might be concerned after seeing the share price drop 22% in the...